In gynecological malignancies, disease diagnosis and prognosis are often assessed through the positive detection rates and serum level changes of tumor markers, such as the commonly used serum tumor markers SCC, HE4, CA125, etc. However, in solitary diagnosis, these can be influenced by inflammatory responses and lesions in other locations, leading to false positives. Here, SERPINB3 is linked to neoplasm.